Last reviewed · How we verify
Tenofovir, emtricitabine, maraviroc
Tenofovir, emtricitabine, maraviroc is a Small molecule drug developed by Hospital Clinic of Barcelona. It is currently FDA-approved.
At a glance
| Generic name | Tenofovir, emtricitabine, maraviroc |
|---|---|
| Sponsor | Hospital Clinic of Barcelona |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- Antiviral Clinical Trial for Long Covid-19 (PHASE2)
- Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy (PHASE3)
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (PHASE2, PHASE3)
- Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen (PHASE2)
- Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection (PHASE1, PHASE2)
- Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tenofovir, emtricitabine, maraviroc CI brief — competitive landscape report
- Tenofovir, emtricitabine, maraviroc updates RSS · CI watch RSS
- Hospital Clinic of Barcelona portfolio CI
Frequently asked questions about Tenofovir, emtricitabine, maraviroc
What is Tenofovir, emtricitabine, maraviroc?
Tenofovir, emtricitabine, maraviroc is a Small molecule drug developed by Hospital Clinic of Barcelona.
Who makes Tenofovir, emtricitabine, maraviroc?
Tenofovir, emtricitabine, maraviroc is developed and marketed by Hospital Clinic of Barcelona (see full Hospital Clinic of Barcelona pipeline at /company/hospital-clinic-of-barcelona).
What development phase is Tenofovir, emtricitabine, maraviroc in?
Tenofovir, emtricitabine, maraviroc is FDA-approved (marketed).